Nothing Special   »   [go: up one dir, main page]

HK1199891A1 - Rapid method for cloning and expression of cognate antibody variable region gene segments - Google Patents

Rapid method for cloning and expression of cognate antibody variable region gene segments

Info

Publication number
HK1199891A1
HK1199891A1 HK15100396.3A HK15100396A HK1199891A1 HK 1199891 A1 HK1199891 A1 HK 1199891A1 HK 15100396 A HK15100396 A HK 15100396A HK 1199891 A1 HK1199891 A1 HK 1199891A1
Authority
HK
Hong Kong
Prior art keywords
cloning
expression
variable region
gene segments
antibody variable
Prior art date
Application number
HK15100396.3A
Other languages
English (en)
Chinese (zh)
Inventor
Simone Hoege
Erhard Kopetzki
Dominique Ostler
Stefan Seeber
Georg Tiefenthaler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47522537&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1199891(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1199891A1 publication Critical patent/HK1199891A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1086Preparation or screening of expression libraries, e.g. reporter assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0635B lymphocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Analytical Chemistry (AREA)
HK15100396.3A 2011-12-21 2015-01-14 Rapid method for cloning and expression of cognate antibody variable region gene segments HK1199891A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11194861 2011-12-21
PCT/EP2012/076155 WO2013092716A1 (en) 2011-12-21 2012-12-19 Rapid method for cloning and expression of cognate antibody variable region gene segments

Publications (1)

Publication Number Publication Date
HK1199891A1 true HK1199891A1 (en) 2015-07-24

Family

ID=47522537

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15100396.3A HK1199891A1 (en) 2011-12-21 2015-01-14 Rapid method for cloning and expression of cognate antibody variable region gene segments

Country Status (12)

Country Link
US (3) US20140302559A1 (xx)
EP (1) EP2794652B1 (xx)
JP (3) JP2015500655A (xx)
KR (1) KR20140104963A (xx)
CN (2) CN104011074A (xx)
BR (1) BR112014013034A2 (xx)
CA (1) CA2854243A1 (xx)
HK (1) HK1199891A1 (xx)
MX (1) MX354049B (xx)
RU (1) RU2612910C2 (xx)
SG (1) SG11201403365TA (xx)
WO (1) WO2013092716A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2417156E (pt) 2009-04-07 2015-04-29 Roche Glycart Ag Anticorpos trivalentes, biespecíficos
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
RU2015153109A (ru) 2009-09-16 2019-01-15 Дженентек, Инк. Содержащие суперспираль и/или привязку белковые комплексы и их применения
AR080793A1 (es) 2010-03-26 2012-05-09 Roche Glycart Ag Anticuerpos biespecificos
KR101586128B1 (ko) 2010-08-24 2016-01-15 에프. 호프만-라 로슈 아게 디술피드 안정화 ― Fv 단편을 포함하는 이중특이적 항체
JP5766296B2 (ja) 2010-12-23 2015-08-19 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用
AR085403A1 (es) 2011-02-28 2013-09-25 Hoffmann La Roche Proteinas monovalentes que se unen a antigenos
CA2825081A1 (en) 2011-02-28 2012-09-07 Birgit Bossenmaier Antigen binding proteins
CN104011074A (zh) * 2011-12-21 2014-08-27 弗·哈夫曼-拉罗切有限公司 用于克隆和表达关联抗体可变区基因区段的快速方法
JP6486686B2 (ja) 2012-02-10 2019-03-20 ジェネンテック, インコーポレイテッド 単鎖抗体及び他のヘテロ多量体
WO2014001324A1 (en) 2012-06-27 2014-01-03 Hoffmann-La Roche Ag Method for selection and production of tailor-made highly selective and multi-specific targeting entities containing at least two different binding entities and uses thereof
BR112014028368A2 (pt) 2012-06-27 2017-11-14 Hoffmann La Roche método de produção de conjugado de região fc de anticorpo, conjugado de região fc de anticorpo e formulação farmacêutica
WO2015000624A1 (en) * 2014-05-19 2015-01-08 F. Hoffmann-La Roche Ag Method for producing antibodies using ovine b-cells and uses thereof
US20160075766A1 (en) * 2013-05-21 2016-03-17 Roche Diagnostics Operations, Inc. Method for producing antibodies using ovine b-cells and uses thereof
CA2922912A1 (en) 2013-10-11 2015-04-16 F. Hoffmann-La Roche Ag Multispecific domain exchanged common variable light chain antibodies
WO2016087416A1 (en) 2014-12-03 2016-06-09 F. Hoffmann-La Roche Ag Multispecific antibodies
WO2017167714A1 (en) 2016-03-30 2017-10-05 F. Hoffmann-La Roche Ag B-cell cultivation method
KR20240133790A (ko) * 2016-12-23 2024-09-04 비스테라, 인크. 결합 폴리펩타이드 및 이의 제조 방법
CN110121554B (zh) 2017-01-02 2023-08-15 豪夫迈·罗氏有限公司 B细胞培养方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815909D0 (en) * 1998-07-21 1998-09-16 Btg Int Ltd Antibody preparation
CN100383244C (zh) * 2003-01-07 2008-04-23 西福根有限公司 用于生产重组多克隆蛋白质的方法
US20060051348A1 (en) 2004-09-09 2006-03-09 Jorn Gorlach Method of producing a plurality of isolated antibodies to a plurality of cognate antigens
US8642513B2 (en) 2005-09-15 2014-02-04 Crucell Holland B.V. Method for preparing immunoglobulin libraries
US20070269868A1 (en) 2006-05-19 2007-11-22 Carvalho Jensen Anne E Culture method for obtaining a clonal population of antigen-specific B cells
PL3187506T3 (pl) 2007-05-21 2019-09-30 Alderbio Holdings Llc Przeciwciała przeciwko IL-6 i ich zastosowanie
CN102272158B (zh) * 2008-11-12 2014-05-07 乔治·K·刘易斯 源自记忆b细胞的人单克隆抗体的快速表达克隆
US8609097B2 (en) * 2009-06-10 2013-12-17 Hoffmann-La Roche Inc. Use of an anti-Tau pS422 antibody for the treatment of brain diseases
EP2524041A4 (en) * 2009-11-16 2013-08-07 Acyte Biotech Pty Ltd RECOMBINANT ANTIBODY VECTOR
WO2011112566A2 (en) * 2010-03-11 2011-09-15 Abbott Laboratories Basigin binding proteins
DK2400298T3 (da) 2010-05-28 2013-09-02 Hoffmann La Roche Enkelt B-celle-dyrkningsfremgangsmåde og specifik antistoffremstilling
CN104011074A (zh) * 2011-12-21 2014-08-27 弗·哈夫曼-拉罗切有限公司 用于克隆和表达关联抗体可变区基因区段的快速方法

Also Published As

Publication number Publication date
EP2794652A1 (en) 2014-10-29
JP6573331B2 (ja) 2019-09-11
WO2013092716A1 (en) 2013-06-27
JP2017221190A (ja) 2017-12-21
EP2794652B1 (en) 2017-11-15
US12024548B2 (en) 2024-07-02
RU2014128987A (ru) 2016-02-20
US20190382469A1 (en) 2019-12-19
CN104011074A (zh) 2014-08-27
SG11201403365TA (en) 2014-07-30
MX2014007256A (es) 2014-08-01
RU2612910C2 (ru) 2017-03-13
CN109810188A (zh) 2019-05-28
MX354049B (es) 2018-02-09
US20170210785A1 (en) 2017-07-27
JP2015500655A (ja) 2015-01-08
JP2019162144A (ja) 2019-09-26
KR20140104963A (ko) 2014-08-29
CA2854243A1 (en) 2013-06-27
BR112014013034A2 (pt) 2017-12-19
US20140302559A1 (en) 2014-10-09

Similar Documents

Publication Publication Date Title
HK1199891A1 (en) Rapid method for cloning and expression of cognate antibody variable region gene segments
HK1252157A1 (zh) 重組病毒產品和抑制dux4表達的方法
IL231259B (en) A furnace with a high diagnosis and a method of operation
ZA201309287B (en) Methods and compositions for selective regulation of protein expression
EP2691121A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TMPRSS6 GENE
PL3829175T3 (pl) Sposób konstruowania listy scalania
EP2662385A4 (en) METHOD FOR IMPROVING THE PHYSICAL PROPERTIES OF ANTIBODIES
GB201103450D0 (en) Apparatus and method of manipulation of articles
SG11201400405TA (en) Caninised antibodies and method for the production of same
HK1201537A1 (en) Anti-kdr antibodies and methods of use -kdr
IL228073A0 (en) Method for the determination of polysorbate
EP2726652A4 (en) PROCESS FOR PROTEIN DISPLAY
HUE052542T2 (hu) Eljárás diszkinézia kezelésére
PL2663662T3 (pl) Sposób odsiarczania stali
ZA201306212B (en) An improved process for the preparation of voriconazole and intermediates thereof
GB2497108B (en) Laser system and associated method of operation
HK1184173A1 (en) Anti-kdr antibodies and methods of use -kdr
GB2487128B (en) Carton and method of assembly thereof
EP2774995A4 (en) METHOD OF MEASURING THE ABUNDANCE OF GENES
EP2707569A4 (en) DORN ARRANGEMENT AND OPERATING PROCEDURE THEREFOR
AU2011902463A0 (en) Method of Desulfurizing Steel
AU2011905262A0 (en) Method of blasting